Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-018741

EVP & Chief Operating Officer acquired 20,604 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ADAMS R MARK EVP & Chief Operating Officer 2021-03-04 Grant or award +20,604 70,604 D
Derivatives
ADAMS R MARK EVP & Chief Operating Officer 2021-03-04 Grant or award · Stock Option (Right to Buy) +51,511 51,511 D
Loading xslF345X03/doc4.xml…